Revision history of "DEVELOPMENT OF A BIOSIMILAR HUMAN INSULIN ANALOGUE TECHNOLOGY" (Q101148)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

7 March 2024

15 January 2024

13 December 2023

12 June 2023

24 May 2023

2 March 2023

  • curprev 19:0519:05, 2 March 2023DG Regio talk contribs 89,475 bytes +6,366 Changed label, description and/or aliases in sk, it, lv, da, fr, cs, pt, et, sv, ga, fi, lt, ro, sl, hr, el, hu, nl, mt, de, es, bg, and other parts

20 October 2022

5 September 2022

18 January 2022

15 January 2022

17 December 2021

7 December 2021

1 December 2021

  • curprev 08:4308:43, 1 December 2021DG Regio talk contribs 18,221 bytes +3,190 Created claim: summary (P836): L’objectif principal du projet est de développer une technologie efficace pour la production d’analogue d’insuline humaine biosimilaire au cours de la période I 2019 XII 2023 et prête à être mise en œuvre dans la période allant jusqu’à la fin de l’année XII 2026. Le principal objectif sera atteint au moyen d’objectifs spécifiques: • développement de constructions d’acide nucléique pour l’expression de la matrice protéique desB30, • développement...
  • curprev 08:4308:43, 1 December 2021DG Regio talk contribs 15,031 bytes +139 Changed label, description and/or aliases in fr: translated_label

29 October 2020

16 October 2020

  • curprev 00:2800:28, 16 October 2020DG Regio talk contribs 15,331 bytes +120 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 00:2800:28, 16 October 2020DG Regio talk contribs 15,211 bytes −143 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 00:2800:28, 16 October 2020DG Regio talk contribs 15,354 bytes +2,607 Created claim: summary (P836): The main objective of the project is to develop an efficient technology for the production of a biosimilar human insulin analogue between I and XII 2023 and ready to be implemented by the end of XII 2026. The main objective will be achieved through specific objectives: • development of structures of nucleic acids for the expression of the protein matrix desB30, • development of efficient strains of hosts for the production of desB30 protein prec...
  • curprev 00:2800:28, 16 October 2020DG Regio talk contribs 12,747 bytes −2,364 Removed claim: summary (P836): The main objective of the project is to develop a productive technology for the production of biosimilar analogues of human insulin in the period I 2019 to XII 2023 and ready for implementation until the end of XII 2026. the main objective will be achieved through specific objectives: • the development of nucleic acid constructs to express the protein matrix desB30,• the development of methods of transformation of the precursor protein to the...

23 September 2020

16 July 2020

22 June 2020

10 June 2020

7 June 2020

26 March 2020

6 March 2020

  • curprev 09:2509:25, 6 March 2020DG Regio talk contribs 13,401 bytes +2,364 Created claim: summary (P836): The main objective of the project is to develop a productive technology for the production of biosimilar analogues of human insulin in the period I 2019 to XII 2023 and ready for implementation until the end of XII 2026. the main objective will be achieved through specific objectives: • the development of nucleic acid constructs to express the protein matrix desB30,• the development of methods of transformation of the precursor protein to the ex...

24 February 2020

18 February 2020

31 January 2020

14 January 2020